Evidence map›Paper›PMID 35456942›Full record

ArticleInternational journal of molecular sciences2022

SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin-Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic Diseases.

Jason Iles, Raminta Zmuidinaite, Christoph Sadee, Anna Gardiner, Jonathan Lacey, Stephen Harding, Jernej Ule, Debra Roblett, Jonathan Heeney, Helen Baxendale and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Zebrafish (International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jason IlesMAPSciences, The iLab, Stannard Way, Bedford MK44 3RZ, UK.
Raminta ZmuidinaiteMAPSciences, The iLab, Stannard Way, Bedford MK44 3RZ, UK.ORCID 0000-0001-7728-6623
Christoph SadeeFrancis Crick Institute, Kings Cross, London NW1 1AT, UK.ORCID 0000-0001-7416-1470
Anna GardinerMAPSciences, The iLab, Stannard Way, Bedford MK44 3RZ, UK.
Jonathan LaceyMAPSciences, The iLab, Stannard Way, Bedford MK44 3RZ, UK.
Stephen HardingThe Binding Site Group Ltd., 8 Calthorpe Road, Edgbaston, Birmingham B15 1QT, UK.
Jernej UleFrancis Crick Institute, Kings Cross, London NW1 1AT, UK.
Debra RoblettFrancis Crick Institute, Kings Cross, London NW1 1AT, UK.
Jonathan HeeneyLaboratory of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK.
Helen BaxendaleRoyal Papworth Hospital NHS Foundation Trust, Cambridge CB2 0AY, UK.
Ray K IlesMAPSciences, The iLab, Stannard Way, Bedford MK44 3RZ, UK.ORCID 0000-0003-0573-9739
University of Cambridge · GBThe Francis Crick Institute · GBPapworth Hospital NHS Foundation Trust · GB

Funding

National Institute for Health Research G107217
6 · The paper itself

Abstract

The immune response to SARS-CoV-2 infection requires antibody recognition of the spike protein. In a study designed to examine the molecular features of anti-spike and anti-nucleocapsid antibodies, patient plasma proteins binding to pre-fusion stabilised complete spike and nucleocapsid proteins were isolated and analysed by matrix-assisted laser desorption ionisation-time of flight (MALDI-ToF) mass spectrometry. Amongst the immunoglobulins, a high affinity for human serum albumin was evident in the anti-spike preparations. Careful mass comparison revealed the preferential capture of advanced glycation end product (AGE) forms of glycated human serum albumin by the pre-fusion spike protein. The ability of bacteria and viruses to surround themselves with serum proteins is a recognised immune evasion and pathogenic process. The preference of SARS-CoV-2 for AGE forms of glycated serum albumin may in part explain the severity and pathology of acute respiratory distress and the bias towards the elderly and those with (pre)diabetic and atherosclerotic/metabolic disease.

Indexed as

COVID-19Diabetes Mellitus, Type 2Prediabetic StateAgedAntibodies, ViralHumansSARS-CoV-2Serum AlbuminSerum Albumin, HumanSpike Glycoprotein, CoronavirusAntibodies, ViralSerum AlbuminSerum Albumin, HumanSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2convalescent plasmaCOVID-19glycated albuminnucleocapsidsemi-automated magnetic rackspike protein

Identifiers

PMID35456942
PMCPMC9030890
OpenAlexW4224291445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.